Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.

International journal of oncology

Volumn 25, Issue 1, 2004, Pages 57-63

  Takeuchi, Hayato ^a   Kanzawa, Takao ^a   Kondo, Yasuko ^a   Komata, Tadashi ^a   Hirohata, Satoshi ^a   Kyo, Satoru ^a   Kondo, Seiji ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CASPASE; CISPLATIN; DNA BINDING PROTEIN; HYBRID PROTEIN; PERTUSSIS TOXIN; TELOMERASE;

ARTICLE; CELL SURVIVAL; DRUG EFFECT; GAMMA RADIATION; GENETIC TRANSFECTION; GENETICS; GLIOMA; HUMAN; METABOLISM; PROMOTER REGION; RADIATION EXPOSURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARMUSTINE; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DNA-BINDING PROTEINS; GAMMA RAYS; GLIOMA; HUMANS; PERTUSSIS TOXIN; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TELOMERASE; TRANSFECTION;

MLCS; MLOWN;

EID: 18044382167     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.25.1.57     Document Type: Article

References (0)